Pacylex Pharma’s phase one trial: Zelenirstat safety in heavily pre-treated patients

Pacylex Pharmaceuticals Inc. has announced the presentation of phase 1 safety and efficacy findings for small molecule drug zelenirstat for cancer treatment.